JCRI-ABTS and USMI Successfully Use Canady Helios™ Cold Plasma in Combination with FOLFIRINOX for the Treatment of Cholangiocarcinoma

by PVA_Admin | Apr 28, 2021 | 2021 Press Release, Press Release

JCRI-ABTS and USMI Successfully Use Canady Helios™ Cold Plasma in Combination with FOLFIRINOX for the Treatment of Cholangiocarcinoma TAKOMA PARK, Md.–(BUSINESS WIRE)–The Jerome Canady Research Institute for Advanced Biological and Technological Sciences...

JCRI-ABTS and USMI Successfully Complete Phase 1 Multi-Center Clinical Trial Using Canady Helios™ Cold Plasma for the Treatment of Cancer

by PVA_Admin | Apr 20, 2021 | 2021 Press Release, Press Release

JCRI-ABTS and USMI Successfully Complete Phase 1 Multi-Center Clinical Trial Using Canady Helios™ Cold Plasma for the Treatment of Cancer TAKOMA PARK, Md.–(BUSINESS WIRE)–The Jerome Canady Research Institute for Advanced Biological and Technological...

Rush Cancer Surgeons Perform Country’s First Cold Plasma Adjuvant Therapy

by PVA_Admin | Dec 21, 2020 | 2020 Press Release, Press Release

Rush Cancer Surgeons Perform Country’s First Cold Plasma Adjuvant Therapy Clinical trial tests ionized beam of room-temperature helium gas that helps body program cancer cells for death Rush University Medical Center cancer surgeons have performed the nation’s first...

Canady Cold Atmospheric Plasma Provides New Insight for the Potential Treatment of Breast Cancer

by PVA_Admin | Sep 16, 2020 | 2020 Press Release, Press Release

Canady Cold Atmospheric Plasma Provides New Insight for the Potential Treatment of Breast Cancer TAKOMA PARK, Md.–(BUSINESS WIRE)–The Jerome Canady Research Institute for Advanced Biological and Technological Sciences (JCRI-ABTS) in collaboration with US...

JCRI-ABTS Seeks FDA Emergency Use Authorization for the Canady Helios Cold Plasma HERO System for the Treatment of COVID-19

by PVA_Admin | Apr 29, 2020 | 2020 Press Release, Press Release

JCRI-ABTS Seeks FDA Emergency Use Authorization for the Canady Helios Cold Plasma HERO System for the Treatment of COVID-19 TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI), a Biomedical and Life Science subsidiary of US Patent...

Canady Helios Cold Plasma Scalpel Successfully Used by Chaim Sheba Medical Center Surgeons to Remove Inoperable Retroperitoneal Cancer

by PVA_Admin | Jan 29, 2020 | 2020 Press Release, Press Release

Canady Helios Cold Plasma Scalpel Successfully Used by Chaim Sheba Medical Center Surgeons to Remove Inoperable Retroperitoneal Cancer TAKOMA PARK, Md.–(BUSINESS WIRE)–A surgical team at The Chaim Sheba Medical Center in Tel HaShomer, Israel, with...